Elon Musk's brain implant company will launch a clinical study in Britain to test how its chips can allow severely paralysed patients to control everyday items with their thoughts.
Neuralink is partnering with University College London Hospitals Trust and Newcastle Hospitals for the project, it said today.
Those living with paralysis due to conditions such as spinal cord injuries and a nervous system disease called amyotrophic lateral sclerosis qualify for the study, the company revealed in a post on X.
The firm began human trials on its brain implant last year after resolving safety concerns flagged by the US Food and Drug Administration.
Five patients around the world with severe paralysis are using its device, according to Neuralink.
